Gergana Nedelcheva
Research Subjects
Research Interests
Gergana Nedelcheva has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Gabriela Tsankova
Department of Microbiology and Virusology, Faculty of Medicine, Medical University, 9000 Varna, Bulgaria
4 shared publications - Neli Ermenlieva
Department of Microbiology and Virusology, Faculty of Medicine, Medical University, 9000 Varna, Bulgaria
3 shared publications - Emilia Georgieva
Training Sector “Medical Laboratory Technician”, Medical College—Varna, Medical University, 9000 Varna, Bulgaria
2 shared publications - Krasimira Laleva
Department of Social Medicine and Healthcare Organization, Medical University of Varna, Varna, Bulgaria
2 shared publications - Sylvia Stamova
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University, 9000 Varna, Bulgaria
2 shared publications - Tatina Todorova
Medical University Varna
2 shared publications
Latest Publications
- 15 May 2025
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 31 (2) , 6218-6223
ANTIMICROBIAL EFFECTS OF ANTIBIOTICS IN COMBINATION WITH OREGANO ESSENTIAL OIL AGAINST ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE
Essential oils from representatives of the family Lamiaceae have proven antimicrobial activity. There is solid scientific evidence for some of them that they have the potential for synergistic interactions with antibiotic agents widely used in clinical practice. The present study aims to investigate the interaction effects of oregano essential oil (OEO) with some conventional antibiotics against Escherichia coli and Klebsiella pneumoniae tested by agar methods. For this purpose, we selected Escherichia coli ATCC25922, Klebsiella pneumoniae ATCC13883, and four clinical isolates representing these species. OEO in a concentration of 2.5% (v/v) was combined with drugs proposed by EUCAST, 2024 (ampicillin, ceftriaxone, meropenem, gentamicin, ciprofloxacin) and tetracycline. The essential oil was analyzed using gas chromatography coupled with mass spectrometry (GC-MS). The analysis of the Oregano essential oil revealed the main component to be carvacrol (81,20%). The results from our study showed that the combinations of OEO with ceftriaxone and meropenem against Escherichia coli and Klebsiella pneumoniae and the combinations of the OEO with gentamycin and ampicillin against Escherichia coli resulted in an increase in the diameter of the zone of inhibition between 1 and 14 mm. Gentamicin and ciprofloxacin combined with OEO did not increase the zone of inhibition in most of the Klebsiella pneumoniae test samples. While examining the effect of tetracycline combined with OEO, we did not obtain unequivocal results for strengthening the antimicrobial effects against the microbes tested.
- 15 May 2025
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 31 (2) , 6218-6223
ANTIMICROBIAL EFFECTS OF ANTIBIOTICS IN COMBINATION WITH OREGANO ESSENTIAL OIL AGAINST ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE
Essential oils from representatives of the family Lamiaceae have proven antimicrobial activity. There is solid scientific evidence for some of them that they have the potential for synergistic interactions with antibiotic agents widely used in clinical practice. The present study aims to investigate the interaction effects of oregano essential oil (OEO) with some conventional antibiotics against Escherichia coli and Klebsiella pneumoniae tested by agar methods. For this purpose, we selected Escherichia coli ATCC25922, Klebsiella pneumoniae ATCC13883, and four clinical isolates representing these species. OEO in a concentration of 2.5% (v/v) was combined with drugs proposed by EUCAST, 2024 (ampicillin, ceftriaxone, meropenem, gentamicin, ciprofloxacin) and tetracycline. The essential oil was analyzed using gas chromatography coupled with mass spectrometry (GC-MS). The analysis of the Oregano essential oil revealed the main component to be carvacrol (81,20%). The results from our study showed that the combinations of OEO with ceftriaxone and meropenem against Escherichia coli and Klebsiella pneumoniae and the combinations of the OEO with gentamycin and ampicillin against Escherichia coli resulted in an increase in the diameter of the zone of inhibition between 1 and 14 mm. Gentamicin and ciprofloxacin combined with OEO did not increase the zone of inhibition in most of the Klebsiella pneumoniae test samples. While examining the effect of tetracycline combined with OEO, we did not obtain unequivocal results for strengthening the antimicrobial effects against the microbes tested.
- Open Access
- 19 June 2024
- Published by John Paul II University in Biała Podlaska in Health Problems of Civilization
- Vol. 19 (3) , 348-356
ETIOLOGICAL AGENTS AND ANTIMICROBIAL SUSCEPTIBILITY OF SURGICAL SITE INFECTION ISOLATES: A SINGLE-CENTER EXPERIENCE IN BULGARIA
Background: Surgical site infections represent the leading complication in surgical departments and are often associated with higher costs, treatment duration and mortality. The present study has evaluated the incidence, the bacteriological profile and the antibiotic resistance pattern of surgical site infection pathogens isolated in the Military Medical Academy in Varna, Bulgaria. Material and methods: A total of 463 isolates were obtained from 957 surgical site samples investigated from January 2019 to December 2021. Their antibiotic susceptibility was determined by the disk diffusion method following the EUCAST guidelines. Results: The most common isolates for the study period were coagulase-negative staphylococci (21.8%) and Escherichia coli (17.3%). Vancomycin, teicoplanin and linezolid were fully effective against staphylococci and enterococci, while colistin, imipenem, meropenem and piperacillin/tazobactam were fully effective against Enterobacteriaceae. Similarly, the most active with 100% retained activity against Pseudomonas aeruginosa and Acinetobacter baumannii was colistin. Conclusions: The etiological structure of surgical site infections in the Military Medical Academy in Varna was comparable to that found in other studies, with a prevalence of staphylococci and enteric bacteria. We found a significant number of isolates resistant to commonly used antibiotics, which limits available treatment options. Strict and active antimicrobial resistance surveillance should be adapted to a larger extent to prevent the emergence of resistant strains.
- 19 June 2024
- Published by John Paul II University in Biała Podlaska in Health Problems of Civilization
- Vol. 19 (3) , 348-356
Open AccessETIOLOGICAL AGENTS AND ANTIMICROBIAL SUSCEPTIBILITY OF SURGICAL SITE INFECTION ISOLATES: A SINGLE-CENTER EXPERIENCE IN BULGARIA
Background: Surgical site infections represent the leading complication in surgical departments and are often associated with higher costs, treatment duration and mortality. The present study has evaluated the incidence, the bacteriological profile and the antibiotic resistance pattern of surgical site infection pathogens isolated in the Military Medical Academy in Varna, Bulgaria. Material and methods: A total of 463 isolates were obtained from 957 surgical site samples investigated from January 2019 to December 2021. Their antibiotic susceptibility was determined by the disk diffusion method following the EUCAST guidelines. Results: The most common isolates for the study period were coagulase-negative staphylococci (21.8%) and Escherichia coli (17.3%). Vancomycin, teicoplanin and linezolid were fully effective against staphylococci and enterococci, while colistin, imipenem, meropenem and piperacillin/tazobactam were fully effective against Enterobacteriaceae. Similarly, the most active with 100% retained activity against Pseudomonas aeruginosa and Acinetobacter baumannii was colistin. Conclusions: The etiological structure of surgical site infections in the Military Medical Academy in Varna was comparable to that found in other studies, with a prevalence of staphylococci and enteric bacteria. We found a significant number of isolates resistant to commonly used antibiotics, which limits available treatment options. Strict and active antimicrobial resistance surveillance should be adapted to a larger extent to prevent the emergence of resistant strains.
- Open Access
- 10 March 2023
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 37 (1) , 309-316
Lyophilized Escherichia coli strains stored for 40–50 years: morphological, serotypic, biochemical characteristics and drug sensitivity
Bacterial cultures are commonly preserved for long periods of time via freeze-drying (lyophilization). Lyophilized bacteria typically retain viability from 5 to 35 years. We investigated the vitality and preservation of some of the characteristic morphological, serotypic and biochemical features of 14 Escherichia coli strains following lyophilized storage for over 40–50 years. We also investigated their susceptibility to conventional antibiotics used in the therapy of infections caused by Enterobacteriaceae representatives. In our study, 14 strains of E. coli related to 11 serological types – O1, O2 (two strains), O5, O7, O11, O20, O25, O26, O29, O111 (two strains) and O125 (two strains) – were used. The lyophilized microorganism ampules were produced in the period of 1971 to 1973 and were stored at 4 °C in a microbial collection for educational purposes at the Medical College – Varna, Bulgaria. Control strains were E. coli ATCC25922, an E. coli strain (used for educational purposes) and three clinical E. coli isolates from urine and wound secretions. The E. coli strains stored for 40–50 years had preserved the studied morphological and biochemical characteristics, as well as those related to their antigenic characteristics and antibiotic sensitivity. Their susceptibility to the tested antimicrobials was analogical to the control reference strain E. coli ATCC25922, indicating that despite the long storage time, all strains retained and demonstrated the typical morphological, stereotypic and biochemical characteristics of the species.
- 10 March 2023
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 37 (1) , 309-316
Open AccessLyophilized Escherichia coli strains stored for 40–50 years: morphological, serotypic, biochemical characteristics and drug sensitivity
Bacterial cultures are commonly preserved for long periods of time via freeze-drying (lyophilization). Lyophilized bacteria typically retain viability from 5 to 35 years. We investigated the vitality and preservation of some of the characteristic morphological, serotypic and biochemical features of 14 Escherichia coli strains following lyophilized storage for over 40–50 years. We also investigated their susceptibility to conventional antibiotics used in the therapy of infections caused by Enterobacteriaceae representatives. In our study, 14 strains of E. coli related to 11 serological types – O1, O2 (two strains), O5, O7, O11, O20, O25, O26, O29, O111 (two strains) and O125 (two strains) – were used. The lyophilized microorganism ampules were produced in the period of 1971 to 1973 and were stored at 4 °C in a microbial collection for educational purposes at the Medical College – Varna, Bulgaria. Control strains were E. coli ATCC25922, an E. coli strain (used for educational purposes) and three clinical E. coli isolates from urine and wound secretions. The E. coli strains stored for 40–50 years had preserved the studied morphological and biochemical characteristics, as well as those related to their antigenic characteristics and antibiotic sensitivity. Their susceptibility to the tested antimicrobials was analogical to the control reference strain E. coli ATCC25922, indicating that despite the long storage time, all strains retained and demonstrated the typical morphological, stereotypic and biochemical characteristics of the species.
- Open Access
- 22 November 2018
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 24 (4) , 2236-2240
MICROBIOLOGICAL MONITORING OF HOSPITAL ENVIRONMENT IN REGION VARNA
- 22 November 2018
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 24 (4) , 2236-2240
Open AccessMICROBIOLOGICAL MONITORING OF HOSPITAL ENVIRONMENT IN REGION VARNA
- Open Access
- 18 December 2017
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 23 (4) , 1828-1833
ANTIMICROBIAL SUSCEPTIBILITY OF CLINICALLY SIGNIFICANT ISOLATES OF ENTEROBACTER SPP., OBTAINED FROM PATIENTS, HOSPITALISED IN VARNA UNIVERSITY HOSPITAL DURING THE PERIOD 2014 – 2016
Purpose: Rapidly increasing antimicrobial resistance in medically important bacterial species from family Enterobacteriaceae is one of the most significant microbiological, clinical and epidemiological issues of modern medicine. The aim of this study is to investigate the antibiotic susceptibility of clinically significant isolates of Enterobacter spp., obtained from patients, hospitalized in University Hospital “Saint Marina” – Varna during the period 2014 – 2016. \ud Material and methods: a total of 433 clinical isolates of Enterobacter spp.from blood cultures, urine and wound secretions were studied. The species identification was made by conventional, semi-automated (Crystal, BD) and automated systems (Phoenix, BD). The susceptibility to piperacillin/tazobactam (TZP), ceftazidime (CAZ), meropenem (MEM), gentamicin (Gm), amikacin (Ak), ciprofloxacin (CIP), levofloxacin (LVX), trimethoprime/sulfamethoxazole (SXT) and tetracycline (Tet) was tested by disc-diffusion method and / or automated system Phoenix 100, BD. The results were interpreted according to EUCAST 2016 guidelines. \ud Results: The resistance in the studied collection of isolates, shown in increasing order is as follows: Аk, 4.2% <LVF, 25.4% <TZP, 37.4% <Tet, 38.7% <SXT, 40% <CIP, 44.1% <Gm, 49.7% <CAZ, 57%. Meropenem demonstrated fully preserved activity. In the group of CAZ resistant isolates, the levels of antimicrobial resistance are: Аk, 5.7% <LVF, 42.9% <Tеt, 52.4% <SXT, 60.3% <TZP, 64.4% <CIP, 84.6% <Gm, 86.2%. The rate of CAZ resistant Enterobacter spp. was 66.9% among the urine isolates, 61.9% - among those from blood culture and 46.3% - in the group of isolates from wound secretions. In the three mentioned groups of isolates, the lowest level of resistance was detected to Ak (1.6%; 4%; 6.9%). The isolates from wound and blood cultures demonstrated the highest level of resistance to Gm (60.3%, 42.9%) and the urine isolates – to Тet (60%) and CIP (56.9%).\ud Conclusions: CAZ resistant Enterobacter spp. demonstrated significantly higher levels of resistance in comparison to the whole studied group especially to quinolones and aminoglycosides. The highest level of CAZ resistant Enterobacter spp. was detected in the group of urine isolates
- 18 December 2017
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 23 (4) , 1828-1833
Open AccessANTIMICROBIAL SUSCEPTIBILITY OF CLINICALLY SIGNIFICANT ISOLATES OF ENTEROBACTER SPP., OBTAINED FROM PATIENTS, HOSPITALISED IN VARNA UNIVERSITY HOSPITAL DURING THE PERIOD 2014 – 2016
Purpose: Rapidly increasing antimicrobial resistance in medically important bacterial species from family Enterobacteriaceae is one of the most significant microbiological, clinical and epidemiological issues of modern medicine. The aim of this study is to investigate the antibiotic susceptibility of clinically significant isolates of Enterobacter spp., obtained from patients, hospitalized in University Hospital “Saint Marina” – Varna during the period 2014 – 2016. \ud Material and methods: a total of 433 clinical isolates of Enterobacter spp.from blood cultures, urine and wound secretions were studied. The species identification was made by conventional, semi-automated (Crystal, BD) and automated systems (Phoenix, BD). The susceptibility to piperacillin/tazobactam (TZP), ceftazidime (CAZ), meropenem (MEM), gentamicin (Gm), amikacin (Ak), ciprofloxacin (CIP), levofloxacin (LVX), trimethoprime/sulfamethoxazole (SXT) and tetracycline (Tet) was tested by disc-diffusion method and / or automated system Phoenix 100, BD. The results were interpreted according to EUCAST 2016 guidelines. \ud Results: The resistance in the studied collection of isolates, shown in increasing order is as follows: Аk, 4.2% <LVF, 25.4% <TZP, 37.4% <Tet, 38.7% <SXT, 40% <CIP, 44.1% <Gm, 49.7% <CAZ, 57%. Meropenem demonstrated fully preserved activity. In the group of CAZ resistant isolates, the levels of antimicrobial resistance are: Аk, 5.7% <LVF, 42.9% <Tеt, 52.4% <SXT, 60.3% <TZP, 64.4% <CIP, 84.6% <Gm, 86.2%. The rate of CAZ resistant Enterobacter spp. was 66.9% among the urine isolates, 61.9% - among those from blood culture and 46.3% - in the group of isolates from wound secretions. In the three mentioned groups of isolates, the lowest level of resistance was detected to Ak (1.6%; 4%; 6.9%). The isolates from wound and blood cultures demonstrated the highest level of resistance to Gm (60.3%, 42.9%) and the urine isolates – to Тet (60%) and CIP (56.9%).\ud Conclusions: CAZ resistant Enterobacter spp. demonstrated significantly higher levels of resistance in comparison to the whole studied group especially to quinolones and aminoglycosides. The highest level of CAZ resistant Enterobacter spp. was detected in the group of urine isolates